El-ASSAL, M. I., and D. SAMUEL. “OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 1, Jan. 2022, pp. 17-27, doi:10.22159/ijpps.2022v14i1.43145.